Pharmacologic treatment with GABAB receptor agonist of methamphetamine-induced cognitive impairment in mice

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 109-112

  Mizoguchi, Hiroyuki ^a,b   Yamada, Kiyofumi ^b,c  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Baclofen; Cognition; GABAB receptor; Methamphetamine; Prepulse inhibition

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; GABOXADOL; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; DOSE RESPONSE; DRUG TREATMENT FAILURE; MEMORY DISORDER; MOUSE; NONHUMAN; PREPULSE INHIBITION; RECOGNITION; SENSORY GATING; STARTLE REFLEX;

EID: 79953031835     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795016976     Document Type: Article

References (41)

1. Mizoguchi, H.; Yamada, K.; Nabeshima, T. Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents. J. Pharmacol. Sci., 2008, 106, 9-14.
2. Mizoguchi, H.; Yamada, K.; Niwa, M.; Mouri, A.; Mizuno, T.; Noda, Y.; Nitta, A.; Itohara, S.; Banno, Y.; Nabeshima, T. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice. J. Neurochem., 2007, 100, 1579-1588.
3. Nakajima, A.; Yamada, K.; Nagai, T.; Uchiyama, T.; Miyamoto, Y.; Mamiya, T.; He, J.; Nitta, A.; Mizuno, M.; Tran, M.H.; Seto, A.; Yoshimura, M.; Kitaichi, K.; Hasegawa, T.; Saito, K.; Yamada, Y.; Seishima, M.; Sekikawa, K.; Kim, H.C.; Nabeshima, T. Role of tumor necrosis factor-α in methamphetamine-induced drug dependence and neurotoxicity. J. Neurosci., 2004, 24, 2212-2225.
4. Yamada, K. Endogenous modulators for drug dependence. Biol. Pharm. Bull., 2008, 31, 1635-1638.
5. Nordahl, T.E.; Salo, R.; Leamon, M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J. Neuropsychiatry. Clin. Neurosci., 2003, 15, 317-325.
6. Simon, S.L.; Domier, C.; Carnell, J.; Brethen, P.; Rawson, R.; Ling, W. Cognitive impairment in individuals currently using methamphetamine. Am. J. Addict., 2000, 9, 222-231.
7. Kalechstein, A.D.; Newton, T.F.; Green, M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J. Neuropsychiatry Clin. Neurosci., 2003, 15, 215-220.
8. Meredith, C.W.; Jaffe, C.; Ang-Lee, K.; Saxon, A.J. Implications of chronic methamphetamine use: a literature review. Harv. Rev. Psychiatry, 2005, 13, 141-154.
9. Mizoguchi, H.; Yamada, K.; Mouri, A.; Niwa, M.; Mizuno, T.; Noda, Y.; Nitta, A.; Itohara, S.; Banno, Y.; Nabeshima T. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. J. Neurochem., 2007, 102, 1548-1560.
10. Scott, J.C.; Woods, S.P.; Matt, G.E.; Meyer, R.A; Heaton, R.K.; Atkinson, J.H.; Grant, I. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev., 2007, 17, 275-297.
11. Kamei, H.; Nagai, T.; Nakano, H.; Togan, Y.; Takayanagi, M.; Takahashi, K.; Kobayashi, K.; Yoshida, S.; Maeda, K.; Takuma, K.; Nabeshima, T.; Yamada, K. Repeated methamphetamine treatment impairs recognition memory through a failure of noveltyinduced ERK 1/2 activation in the prefrontal cortex of mice. Biol. Psychiatry, 2006, 59, 75-84.
12. Nagai, T.; Takuma, K.; Dohniwa, M.; Ibi, D.; Mizoguchi, H.; Kamei, H.; Nabeshima, T.; Yamada, K. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl), 2007, 194, 21-32.
13. Meltzer, H.Y.; McGurk, S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull., 1999, 25, 233-255.
14. Woodward, N.D.; Purdon, S.E.; Meltzer, H.Y.; Zald, D.H. A metaanalysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol., 2005, 8, 457-472.
15. Valjent, E.; Corvol, J.C.; Pages, C.; Besson, M.J.; Maldonado, R.; Caboche, J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci., 2000, 20, 8701-8709.
16. Zanassi, P.; Paolillo, M.; Feliciello, A.; Avvedimento, E.V.; Gallo, V.; Schinelli, S. cAMP-dependent protein kinase induces cAMPresponse element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J. Biol. Chem., 2001, 276, 11487-11495.
17. Ito, Y.; Takuma, K.; Mizoguchi, H.; Nagai, T.; Yamada, K. A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) improves methamphetamineinduced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J. Pharmacol. Exp. Ther., 2007, 320, 819-827.
18. Mizoguchi, H.; Yamada, K.; Mizuno, M.; Mizuno, T.; Nitta, A.; Noda, Y.; Nabeshima, T. Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Mol. Pharmacol., 2004, 65, 1293-1301.
19. Nagai, T.; Kamei, H.; Dohniwa, M.; Takayanagi, M.; Suzuki, M.; Matsuya, T.; Nabeshima, T.; Takuma, K.; Yamada, K. Involvement of hippocampal extracellular signal-regulated kinase 1/2 in spatial working memory in rats. Neuroreport, 2006, 17, 1453-1457.
20. Nagai, T.; Takuma, K.; Kamei, H.; Ito, Y.; Nakamichi, N.; Ibi, D.; Nakanishi, Y.; Murai, M.; Mizoguchi, H.; Nabeshima, T.; Yamada, K. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learn. Mem., 2007, 14, 117-125.
21. Mizoguchi, H.; Takuma, K.; Fukakusa, A.; Ito, Y.; Nakatani, A.; Ibi, D.; Kim, H.C.; Yamada, K. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl), 2008, 196, 233-241.
22. Tepper, J.M.; Lee, C.R. GABAergic control of substantia nigra dopaminergic neurons. Prog. Brain. Res., 2007, 160, 189-208.
23. Erhardt, S.; Mathe, J.M.; Chergui, K.; Engberg, G.; Svensson, T.H. GABAB receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn- Schmiedebergs Arch. Pharmacol., 2002, 365, 173-180.
24. Brebner, K.; Ahn, S.; Phillips, A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl), 2005, 177, 409-417.
25. Westerink, B.H.; Kwint, H.F.; deVries, J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci., 1996, 16, 2605-2611.
26. Cousins, M.S.; Roberts, D.C.; De, Wit. H. GABAB receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend., 2002, 65, 209-220.
27. Bartholini, G. GABA receptor agonists: pharmacological spectrum and therapeutic action. Med. Res. Rev., 1985, 5, 55-75.
28. Bartoletti, M.; Gubellini, C.; Ricci, F.; Gaiardi, M. Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behav. Pharmacol., 2005, 16, 553-558.
29. Bartoletti, M.; Gubellini, C.; Ricci, F.; Gaiardi, M. The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behav. Pharmacol., 2004, 15, 397-401.
30. Escher, T.; Mittleman, G. Effects of ethanol and GABAB drugs on working memory in C57BL/6J and DBA/2J mice. Psychopharmacology (Berl), 2004, 176, 166-174.
31. Lin, S.K.; Chen, C.K.; Ball, D.; Liu, H.C.; Loh, E.W. Genderspecific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder. Pharmacogenomics J., 2003, 3, 349-355.
32. Nishiyama, T.; Ikeda, M.; Iwata, N.; Suzuki, T.; Kitajima, T.; Yamanouchi, Y.; Sekine, Y.; Iyo, M.; Harano, M.; Komiyama, T.; Yamada, M.; Sora, I.; Ujike, H.; Inada, T.; Furukawa, T.; Ozaki, N. Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics J., 2005, 5, 89-95.
33. Rose, M.E.; Grant J.E. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann. Clin. Psychiatry, 2008, 20, 145-155.
34. Arai, S.; Takuma, K.; Mizoguchi, H.; Ibi, D.; Nagai, T.; Kamei, H.; Kim, H.C.; Yamada, K. GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice. Eur. J. Pharmacol., 2009, 602, 101-104.
35. Vanhoose, A.M.; Emery, M.; Jimenez, L.; Winder, D.G. ERK activation by G-protein-coupled receptors in mouse brain is receptor identity-specific. J. Biol. Chem., 2002, 277, 9049-9053.
36. Castellanos, F.X.; Fine, E.J.; Kaysen, D.L.; Kozuch, P.L.; Hamburger, S.D.; Rapoport, J.L.; Hallett, M. Sensorimotor gating in boys with Tourette's syndrome and ADHD. Biol. Psychiatry., 1996, 39, 33-41.
37. Swerdlow, N.R.; Braff, D.L.; Taaid, N.; Geyer, M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry, 1994, 51, 139-154.
38. Takahashi, K.; Nagai, T.; Kamei, H.; Maeda, K.; Matsuya, T.; Arai, S.; Mizoguchi, H.; Yoneda, Y.; Nabeshima, T.; Takuma, K.; Yamada, K. Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol. Psychiatry, 2007, 62, 148-157.
39. Arai, S.; Takuma, K.; Mizoguchi, H.; Ibi, D.; Nagai, T.; Takahashi, K.; Kamei, H.; Nabeshima, T.; Yamada, K. Involvement of pallidotegmental neurons in methamphetamine- and MK-801-Induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacology, 2008, 33, 3164-3175.
40. Bortolato, M.; Frau, R.; Aru, G.N.; Orrù, M.; Gessa, G.L. Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine. Psychopharmacology (Berl), 2004, 171, 322-330.
41. Bortolato, M.; Frau, R.; Orrù, M.; Piras, A.P.; Fà, M.; Tuveri, A.; Puligheddu, M.; Gessa, G.L.; Castelli, M.P.; Mereu, G.; Marrosu, F. Activation of GABAB receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. Psychopharmacology (Berl), 2007, 194, 361-369.